plasmid 21 option 1
plasmid #21 option 2
plasmid #21 option 3
  • Load image into Gallery viewer, plasmid 21 option 1
  • Load image into Gallery viewer, plasmid #21 option 2
  • Load image into Gallery viewer, plasmid #21 option 3

Plasmid #21 – DISCONTINUED

Regular price
$240.00
Sale price
$240.00
Regular price
Sold out
Unit price
per 

Plasmid #21 enables the tagging of target proteins with N-terminal CL7 and His8. There are three options for the 5’ placement of target genes (see cloning options below). XhoI is the 3’ cloning site.  All three options require a stop codon encoded in the 3’ cloning primer. 

SKU: 20-1021

EXPRESSION
Transcription is induced with IPTG and driven by the T7 RNA polymerase. The plasmid is designed for expression in E. coli

PEPTIDE TAG
The N-terminal CL7 tag is upstream of several protease cleavage sites and a His8 tag. 

CLEAVAGE SITE(S)
Plasmid #21 contains two PreScission protease (PSC) cleavage sites between the CL7 and His8 tags. Downstream of the His8 tag are SUMO and Sortase A cleavage sites. 

OTHER TAGS
The coding region begins with an N-terminal Trx tag and includes a His8 tag between the PSC and SUMO cleavage sites, upstream of the target protein.

CLONING OPTIONS
1. HindIII/XhoI Insertion Site – Trx | CL7 | PSC | 44-Amino Acid Linker | PSC | His8 Tag | SUMO | 13-Amino Acid Linker | SRT | Gene of Interest

2. KpnI/XhoI Insertion Site – Trx | CL7 | PSC | 44-Amino Acid Linker | PSC | His8 Tag | SUMO | 3-Amino Acid Linker | Gene of Interest

3. Bsu36I/XhoI Insertion Site – Trx | CL7 | PSC | 44-Amino Acid Linker | PSC | His8 Tag | SUMO | Gene of Interest

    The Bsu361/XhoI insertion scheme maintains the Gene of Interest’s wildtype sequence without adding any extra residues. The N-terminus of the Gene of Interest must include the following sequence to complete the SUMO C-terminal sequence:

    EXPIRATION | 6 months from receipt when stored as directed

    Plasmid Sequences are available on the Plasmid Guide Page

    Use of TriAltus products falls under our limited license agreement and is for non-profit research use only. For commercial use, please contact us for licensing.